Protein kinase C-δ signaling regulates glucagon secretion from pancreatic islets.

Accumulating evidence supports the "glucagonocentric hypothesis", in which antecedent α-cell failure and inhibition of glucagon secretion are responsible for diabetes progression. Protein kinase C (PKC) is involved in glucagon secretion from α-cells, although which PKC isozyme is involved and the mechanism underlying this PKC-regulated glucagon secretion remains unknown. Here, the involvement of PKCδ in the onset and progression of diabetes was elucidated. Immunofluorescence studies revealed that PKCδ was expressed and activated in α-cells of STZ-induced diabetic model mice. Phorbol 12-myristate 13-acetate (PMA) stimulation significantly augmented glucagon secretion from isolated islets. Pre-treatment with quercetin and rottlerin, PKCδ signaling inhibitors, significantly suppressed the PMA-induced elevation of glucagon secretion. While Go6976, a Ca2+-dependent PKC selective inhibitor did not suppress glucagon secretion. Quercetin suppressed PMA-induced phosphorylation of Tyr311 of PKCδ in isolated islets. However, quercetin itself had no effect on either glucagon secretion or glucagon mRNA expression. Our data suggest that PKCδ signaling inhibitors suppressed glucagon secretion. Elucidation of detailed signaling pathways causing PKCδ activation in the onset and progression of diabetes followed by the augmentation of glucagon secretion could lead to the identification of novel therapeutic target molecules and the development of novel therapeutic drugs for diabetes. J. Med. Invest. 64: 122-128, February, 2017.

[1]  N. Takeda,et al.  Disruption of Heat Shock Protein 90 (Hsp90)-Protein Kinase Cδ (PKCδ) Interaction by (−)-Maackiain Suppresses Histamine H1 Receptor Gene Transcription in HeLa Cells* , 2015, The Journal of Biological Chemistry.

[2]  N. Takeda,et al.  Maackiain is a novel antiallergic compound that suppresses transcriptional upregulation of the histamine H1 receptor and interleukin-4 genes , 2015, Pharmacology research & perspectives.

[3]  M. Roth,et al.  Erratum: Correction: "Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway," (Proc Natl Acad Sci USA (2015) 112:8 (2503-2508) DOI: 10.1073/pnas.1424934112) , 2015 .

[4]  M. Roth,et al.  Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway , 2015, Proceedings of the National Academy of Sciences.

[5]  N. Takeda,et al.  Quercetin inhibits transcriptional up-regulation of histamine H1 receptor via suppressing protein kinase C-δ/extracellular signal-regulated kinase/poly(ADP-ribose) polymerase-1 signaling pathway in HeLa cells. , 2013, International immunopharmacology.

[6]  B. Viollet,et al.  Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP , 2016 .

[7]  C. Talchai,et al.  Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure , 2012, Cell.

[8]  M. J. Charron,et al.  Metabolic manifestations of insulin deficiency do not occur without glucagon action , 2012, Proceedings of the National Academy of Sciences.

[9]  T. Kitamura,et al.  FoxO1 Gain of Function in the Pancreas Causes Glucose Intolerance, Polycystic Pancreas, and Islet Hypervascularization , 2012, PloS one.

[10]  A. Cherrington,et al.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. , 2012, The Journal of clinical investigation.

[11]  N. Takeda,et al.  Involvement of Protein Kinase Cδ/Extracellular Signal-regulated Kinase/Poly(ADP-ribose) Polymerase-1 (PARP-1) Signaling Pathway in Histamine-induced Up-regulation of Histamine H1 Receptor Gene Expression in HeLa Cells* , 2011, The Journal of Biological Chemistry.

[12]  J. Alcamí,et al.  Protein Kinase Cθ Is a Specific Target for Inhibition of the HIV Type 1 Replication in CD4+ T Lymphocytes* , 2011, The Journal of Biological Chemistry.

[13]  C. Kahn,et al.  PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. , 2011, The Journal of clinical investigation.

[14]  J. Holst,et al.  Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function , 2011, Diabetes.

[15]  M. J. Charron,et al.  Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice , 2011, Diabetes.

[16]  J. Alcamí,et al.  Protein Kinase C Is a Specific Target for Inhibition of the HIV Type 1 Replication in CD 4 T Lymphocytes * , 2011 .

[17]  D. R. Laybutt,et al.  Deletion of protein kinase Cδ in mice modulates stability of inflammatory genes and protects against cytokine-stimulated beta cell death in vitro and in vivo , 2011, Diabetologia.

[18]  J. Holst,et al.  The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action , 2010, Diabetes.

[19]  C. Schmitz‐Peiffer,et al.  PKCδ Blues for the β-Cell , 2010, Diabetes.

[20]  C. Schmitz‐Peiffer,et al.  PKCdelta blues for the beta-cell. , 2010, Diabetes.

[21]  L. Eliasson,et al.  Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCα and PKCδ , 2010, Diabetologia.

[22]  C. Nunemaker,et al.  A Practical Guide to Rodent Islet Isolation and Assessment , 2009, Biological Procedures Online.

[23]  W. Uhl,et al.  Functional Assessment of Pancreatic β-Cell Area in Humans , 2009, Diabetes.

[24]  K. Polonsky,et al.  Insulin signaling in alpha cells modulates glucagon secretion in vivo. , 2009, Cell metabolism.

[25]  W. Uhl,et al.  Functional assessment of pancreatic beta-cell area in humans , 2009 .

[26]  S. Steinberg.  Structural basis of protein kinase C isoform function. , 2008, Physiological reviews.

[27]  S. Soltoff,et al.  Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. , 2007, Trends in pharmacological sciences.

[28]  M. Kanter,et al.  Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. , 2005, Pharmacological research.

[29]  C. Kahn,et al.  Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. , 2004, Diabetes.

[30]  Bo Ahrén,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(5):2078–2084 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-031907 Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels , 2022 .

[31]  P. Halban,et al.  Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications , 2004, Diabetologia.

[32]  V. Menon,et al.  Quercetin allievates oxidative stress in streptozotocin‐induced diabetic rats , 2004, Phytotherapy research : PTR.

[33]  H. Matsuzaki,et al.  Protein Kinase Cδ (PKCδ): Activation Mechanisms and Functions , 2002 .

[34]  P. Jones,et al.  Role of protein kinase C in arginine-induced glucagon secretion from isolated rat islets of Langerhans. , 1988, Journal of molecular endocrinology.

[35]  S. Howell,et al.  Enhancement of glucagon secretion from isolated rat islets of Langerhans by phorbol 12-myristate 13-acetate. , 1986, The Biochemical journal.

[36]  P. Raskin,et al.  Effect of Insulin Therapy on the Profiles of Plasma Immunoreactive Glucagon in Juvenile-type and Adult-type Diabetics , 1978, Diabetes.